Search Results - "Qayoom, Hina"

Unravelling the therapeutic potential of dual TGFβ-1 and CXCR4 inhibition in breast cancer using computational strategies.

Authors: Haq, Burhan Ul Sofi, Shazia Qayoom, Hina et al.

Source: PLoS ONE. 12/5/2025, Vol. 20 Issue 12, p1-27. 27p.

Targeting mutant p53: a key player in breast cancer pathogenesis and beyond.

Authors: Qayoom, Hina Haq, Burhan Ul Sofi, Shazia et al.

Source: Cell Communication & Signaling. 10/10/2024, Vol. 22 Issue 1, p1-14. 14p.

Expression of DDX49 in breast cancer and its mechanism regulating the proliferation and metastasis of breast cancer cells.

Authors: Wang, Yuanbin Yang, Lijun Li, Xiangli et al.

Source: Growth Factors. Feb2025, Vol. 43 Issue 1, p45-55. 11p.

Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesis.

Authors: Qayoom, Hina Bashir, Sania Khan, Rumaisa et al.

Source: Computational Biology & Chemistry; Oct2024, Vol. 112, pN.PAG-N.PAG, 1p

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis.

Authors: Haq, Burhan Ul Qayoom, Hina Sofi, Shazia et al.

Source: Frontiers in pharmacology 2024.

Journal Info: Publisher: Frontiers Media S.A. ISSN: 1663-9812

Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis.

Authors: Ul Haq, Burhan Qayoom, Hina Sofi, Shazia et al.

Source: Frontiers in pharmacology 2024.

Journal Info: Publisher: Frontiers Media S.A. ISSN: 1663-9812

Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors.

Authors: Shabir, Aisha Qayoom, Hina Ul Haq, Burhan et al.

Source: Frontiers in pharmacology 2024.

Journal Info: Publisher: Frontiers Media S.A. ISSN: 1663-9812